Bnp Paribas Asset Management Holding S.A. Charles River Laboratories International, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

  • $41 Billion
  • Q2 2025

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,909 shares of CRL stock, worth $372,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,909
Previous 1,496 27.61%
Holding current value
$372,789
Previous $225,000 28.89%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025
BUY
$99.75 - $151.89 $41,196 - $62,730
413 Added 27.61%
1,909 $290,000
Q1 2025

May 13, 2025
SELL
$150.52 - $190.14 $469,471 - $593,046
-3,119 Reduced 67.58%
1,496 $225,000
Q4 2024

Feb 11, 2025
SELL
$178.58 - $220.69 $24.6 Million - $30.4 Million
-137,811 Reduced 96.76%
4,615 $852,000
Q3 2024

Nov 08, 2024
SELL
$187.96 - $245.29 $12 Million - $15.6 Million
-63,588 Reduced 30.87%
142,426 $28.1 Million
Q2 2024

Jul 29, 2024
BUY
$206.39 - $268.73 $406,588 - $529,398
1,970 Added 0.97%
206,014 $42.6 Million
Q1 2024

May 08, 2024
SELL
$203.52 - $273.43 $10.3 Million - $13.9 Million
-50,772 Reduced 19.92%
204,044 $55.3 Million
Q4 2023

Feb 09, 2024
BUY
$164.52 - $238.84 $285,771 - $414,865
1,737 Added 0.69%
254,816 $60.2 Million
Q3 2023

Nov 13, 2023
BUY
$194.44 - $217.61 $10.2 Million - $11.4 Million
52,228 Added 26.0%
253,079 $49.6 Million
Q2 2023

Aug 08, 2023
BUY
$183.71 - $210.25 $6.09 Million - $6.97 Million
33,172 Added 19.78%
200,851 $42.2 Million
Q1 2023

May 08, 2023
SELL
$191.89 - $259.92 $5.44 Million - $7.37 Million
-28,357 Reduced 14.47%
167,679 $33.8 Million
Q4 2022

Feb 09, 2023
BUY
$197.11 - $250.07 $4.52 Million - $5.73 Million
22,918 Added 13.24%
196,036 $42.7 Million
Q3 2022

Nov 10, 2022
SELL
$182.44 - $250.54 $3.33 Million - $4.58 Million
-18,266 Reduced 9.54%
173,118 $34.1 Million
Q2 2022

Aug 04, 2022
BUY
$204.13 - $302.4 $1.11 Million - $1.65 Million
5,461 Added 2.94%
191,384 $41 Million
Q1 2022

May 12, 2022
BUY
$255.51 - $362.11 $3.17 Million - $4.49 Million
12,387 Added 7.14%
185,923 $52.8 Million
Q4 2021

Feb 09, 2022
BUY
$351.38 - $448.68 $4.83 Million - $6.17 Million
13,755 Added 8.61%
173,536 $65.4 Million
Q3 2021

Nov 08, 2021
BUY
$372.64 - $458.3 $1.65 Million - $2.02 Million
4,416 Added 2.84%
159,781 $65.9 Million
Q2 2021

Aug 05, 2021
SELL
$294.17 - $371.65 $14.1 Million - $17.8 Million
-48,004 Reduced 23.6%
155,365 $57.5 Million
Q1 2021

May 05, 2021
SELL
$249.67 - $299.48 $766,237 - $919,104
-3,069 Reduced 1.49%
203,369 $58.9 Million
Q4 2020

Feb 12, 2021
BUY
$222.0 - $252.62 $1.26 Million - $1.44 Million
5,690 Added 2.83%
206,438 $51.6 Million
Q3 2020

Nov 09, 2020
BUY
$175.56 - $226.45 $6.85 Million - $8.83 Million
39,002 Added 24.11%
200,748 $45.5 Million
Q2 2020

Aug 04, 2020
BUY
$118.84 - $189.72 $2.08 Million - $3.32 Million
17,482 Added 12.12%
161,746 $28.2 Million
Q1 2020

May 12, 2020
BUY
$98.9 - $178.34 $1.66 Million - $2.99 Million
16,755 Added 13.14%
144,264 $18.2 Million
Q4 2019

Feb 11, 2020
SELL
$126.05 - $152.76 $997,181 - $1.21 Million
-7,911 Reduced 5.84%
127,509 $19.5 Million
Q3 2019

Nov 12, 2019
SELL
$125.07 - $143.67 $78,543 - $90,224
-628 Reduced 0.46%
135,420 $17.9 Million
Q2 2019

Aug 02, 2019
SELL
$123.4 - $148.55 $2.33 Million - $2.81 Million
-18,906 Reduced 12.2%
136,048 $19.3 Million
Q1 2019

Apr 26, 2019
BUY
$104.82 - $146.73 $35,219 - $49,301
336 Added 0.22%
154,954 $22.5 Million
Q4 2018

Feb 13, 2019
BUY
$105.09 - $137.23 $951,695 - $1.24 Million
9,056 Added 6.22%
154,618 $17.3 Million
Q3 2018

Nov 13, 2018
SELL
$112.11 - $134.54 $909,884 - $1.09 Million
-8,116 Reduced 5.28%
145,562 $19.6 Million
Q2 2018

Aug 01, 2018
BUY
$102.37 - $117.25 $933,819 - $1.07 Million
9,122 Added 6.31%
153,678 $17.3 Million
Q1 2018

May 07, 2018
BUY
$98.19 - $115.2 $567,047 - $665,280
5,775 Added 4.16%
144,556 $15.4 Million
Q4 2017

Feb 01, 2018
SELL
$100.43 - $118.09 $563,814 - $662,957
-5,614 Reduced 3.89%
138,781 $15.2 Million
Q3 2017

Nov 02, 2017
BUY
$96.72 - $109.26 $14 Million - $15.8 Million
144,395
144,395 $15.6 Million

Others Institutions Holding CRL

# of Institutions
628
Shares Held
52.5M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.93B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email